Copy For Citation
SEVER B., ALTINTOP M. D., ÖZDEMİR A.
LETTERS IN DRUG DESIGN & DISCOVERY, vol.18, no.1, pp.3-15, 2021 (SCI-Expanded)
Article / Article
LETTERS IN DRUG DESIGN & DISCOVERY
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Biotechnology Research Abstracts, Chemical Abstracts Core, EMBASE
Bis-pyrazoline, dithiocarbamate, oxadiazole, antifungal activity, aspergillosis and candidiasis, BIOLOGICAL EVALUATION, DERIVATIVES BEARING, DRUG-RESISTANCE, GROWTH, DISCOVERY, VIRULENCE, MOIETY
Anadolu University Affiliated:
Background: Due to the increasing number of cases of invasive fungal infections (IFIs), there is an urgent need to identify potent antifungal agents capable of combating IFIs. Pyrazolines are one such class of therapeutically active agents that could be considered to fulfill this need.